Aminocaproic acid (Amicar)

From - A Hematology Oncology Wiki
Jump to navigation Jump to search

General information

Class/mechanism: Inhibits fibrinolysis by inhibiting plasminogen activators and via antiplasmin activity.[1][2][3]
Route: IV, PO
Extravasation: no information

For conciseness and simplicity, currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, Medscape,UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

Also known as

  • Generic names: 6-aminohexanoic acid, epsilon aminocaproic acid, ε-aminocaproic acid, ε-Ahx
  • Brand name: Amicar